Literature DB >> 28921645

Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future.

Diane R Mould1, Paul R Hutson2.   

Abstract

Keywords:  anticancer; dosing; exposure/response; pharmacodynamics; population modeling; review; simulation

Mesh：

Substances：

Year:  2017        PMID： 28921645     DOI： 10.1002/jcph.983

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  4 in total

1.  Design and Analysis of a Sample-and-Hold CMOS Electrochemical Sensor for Aptamer-based Therapeutic Drug Monitoring.

Authors:  Jun-Chau Chien; Sam W Baker; H Tom Soh; Amin Arbabian
Journal:  IEEE J Solid-State Circuits       Date:  2020-09-16       Impact factor: 5.013

2.  Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings.

Authors:  Wen Yin; Cheng Gao; Yaomin Xu; Bingshan Li; Douglas M Ruderfer; You Chen
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2018-05-18

3.  Exposure-response modeling improves selection of radiation and radiosensitizer combinations.

Authors:  Tim Cardilin; Joachim Almquist; Mats Jirstrand; Astrid Zimmermann; Floriane Lignet; Samer El Bawab; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-08       Impact factor: 2.745

Review 4.  The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.

Authors:  Thierry Buclin; Yann Thoma; Nicolas Widmer; Pascal André; Monia Guidi; Chantal Csajka; Laurent A Decosterd
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.